Limited Period Offer:Be a PRO for 1 month @Rs49/-Multiple payment options available. Know More
you are here: HomeNewsTrendsHealth

Salesforce CEO Marc Benioff to send medical supplies to India

The CEO said that the company will be loading Boeing 787 with medical supplies and will land it in India next week. The 787 Dreamliner is Boeing's most fuel-efficient plane.

April 29, 2021 / 03:45 PM IST
Marc Benioff  (Image: Reuters)

Marc Benioff (Image: Reuters)


Marc Benioff, founder of Cloud software giant Salesforce on April 29 said that the company is loading a Boeing 787 with medical supplies and will land it in India next week.

"Salesforce is loading a 787 with medical supplies and will land it in India next week. All of our hearts and prayers are with our brothers and sisters in India. May they all be protected, healed, & blessed," the founder said in a tweet.

As per the economic times report, the company has already announced that it would be donating $1 million in India.

The donated money will be used towards local partners focused on medical equipment sourcing, community isolation centres and creating vaccine awareness in the country.

Also Read: COVID-19: India begins accepting foreign aid for the first time in 16 years

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

In India, Salesforce has over 4000 employees.

In a press release the company said, "there is heightened demand for plasma donations throughout India, so we have built a process in Quip and using other technology tools to connect our employees — who may be donors or donees – to facilitate these conversations safely and securely,"

Also Read: UN agencies procuring 7,000 oxygen concentrators, COVID-19 testing machines, PPEs for India: UN spokesperson

Employees in India are also manning a 24/7 volunteer helpline to provide Salesforce employees and families COVID related information.

Follow our LIVE blog for latest updates of the novel coronavirus pandemic

Meanwhile, Global and Indian firms are flexing their industrial muscle to help the world's second biggest population battle coronavirus, coming to the rescue of a public health system buckling under the weight of surging infections and deaths.

Amazon.com, Intel and Google, as well as Indian firms Tata Sons, Reliance Industries and JSW Steel have pitched in with everything from airlifts of medical equipment and funding pledges to making medical oxygen.

India saw a record single day rise of 3,79,257 new coronavirus infections pushing the total tally of COVID-19 cases to 1,83,76,524, while active cases crossed the 30-lakh mark, according to the Union Health Ministry data updated on Thursday.

The death toll increased to 2,04,832 with a record 3,645 daily new fatalities, the data updated at 8 am showed.
Registering a steady increase, the active cases have increased to 30,84,814 comprising 16.79 per cent of the total infections, while the national COVID-19 recovery rate has further dropped to 82.10 percent.


The Health Ministry also said that the cumulative number of COVID-19 vaccine doses administered in the country has crossed 15 crore.


(With inputs from agencies)
Follow our full coverage of the coronavirus pandemic here.
Moneycontrol News
first published: Apr 29, 2021 03:45 pm

stay updated

Get Daily News on your Browser
Sections